Chemomab Therapeutics Ltd.
(NASDAQ : CMMB)

( )
CMMB PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. -6.45%171.140.0%$784.22m
AMGNAmgen, Inc. 0.43%248.361.5%$592.28m
VRTXVertex Pharmaceuticals, Inc. 1.66%298.831.9%$438.24m
GILDGilead Sciences, Inc. 0.65%62.001.0%$379.78m
REGNRegeneron Pharmaceuticals, Inc. -1.35%622.152.6%$351.29m
NVAXNovavax, Inc. -29.64%40.2875.7%$335.10m
SNSSSunesis Pharmaceuticals, Inc. -12.15%3.470.7%$242.57m
ILMNIllumina, Inc. -3.67%214.803.3%$229.68m
BIIBBiogen, Inc. 0.01%217.591.8%$197.59m
BNTXBioNTech SE -7.14%157.210.0%$155.97m
GOVXGeoVax Labs, Inc. -0.35%2.860.0%$145.88m
CRSPCRISPR Therapeutics AG -7.69%75.130.6%$117.81m
PLRXPliant Therapeutics, Inc. 11.19%21.160.0%$108.38m
RYTMRhythm Pharmaceuticals, Inc. 7.19%22.650.0%$105.42m
BMRNBioMarin Pharmaceutical, Inc. 0.00%95.704.2%$98.26m

Company Profile

Chemomab Therapeutics Ltd. operates as a clinical-stage biotech company. It discovers and develops therapeutics for conditions with unmet need that involve Inflammation and fibrosis. The company was founded by Adi Mor on September 22, 2011 and is headquartered in Tel Aviv, Israel.